Serena Fries Smith
Serena Smith, Director of Market Intelligence & Strategy – mRNA Vaccines & Therapeutics at Thermo Fisher Scientific
Taking the mRNA Highway from Development to Commercialization
April 8, 2022
Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines. But how can the industry get these formulations to patients more rapidly? It’s important to keep the destination in mind at the very beginning of the journey – and that means paying attention to process robustness, raw materials, and how partners can help.
1 min read
The Upstream/Downstream Process Balancing Act
March 22, 2019
Early collaboration and open communication between upstream and downstream are crucial to ensure a consistent end-to-end bioprocess.
0 min read
Process Intensification: Getting More From Less
January 17, 2019
Intensifying or simplifying your bioprocess can mean more product, shorter manufacturing times, or lower costs –understanding what matters most is key to making the right decisions.
0 min read
Keys to Consistent Bioprocessing
November 14, 2018
The development of a robust and consistent bioprocess requires a systematic and risk-based approach to identify the right process parameters and raw materials.
0 min read
Newsletters
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
